COVID-19 therapies and their impact on QT interval prolongation: A multicentre retrospective study on 196 patients

COVID-19 therapies and their impact on QT interval prolongation: A multicentre retrospective study on 196 patients

Background: SARS-CoV-2 infection has caused a global pandemic. Many of the medications identified to treat COVID-19 could be connected with QTc prolongation and its consequences. Methods: Non-ICU hospitalized patients of the three centres involved in the study from the 19th of March to the 1st of Ma...

Full description

Bibliographic Details
Main Authors: M. Bianco, C.A. Biolè, S. Campagnuolo, F. Pietrangiolillo, A. Spirito, A. Galluzzo, I. Nuñez-Gil, P. Destefanis, A. Luciano, P. Carvalho, G.P. Varalda, A. Previti, M. Gravellone, A. Travieso Gonzalez, F. Ugo, G. Pivano, F. Rametta, A. Perboni, R. Pozzi, L. Montagna, E. Cerrato
Format: Article
Language:English
Published: Elsevier 2020-10-01
Series:International Journal of Cardiology: Heart & Vasculature
Subjects:
QT interval
COVID-19
Hydroxycloroquine
Azithromycin
Non ICU-patients
Online Access:http://www.sciencedirect.com/science/article/pii/S2352906720303353

Internet

http://www.sciencedirect.com/science/article/pii/S2352906720303353

Similar Items